Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 14 clinical trials
Better Understanding Slow Language Impairment

This study was designed to examine the development of children aged 6 to 10 with slow language impairment (SLI). The aim was threefold: (1) to investigate language skills of children with SLI at different levels - formal, semantic, pragmatic- in comparison with those of control children; (2) to test a …

  • 0 views
  • 25 Jan, 2021
  • 1 location
Botulinum Toxin in Raynaud's Phenomenon

Raynaud's Phenomenon (RP) is the most common vasospastic disorder encountered by hand surgeons with an estimated prevalence of 5% in the general population. It's manifestations are broad, and

botulinum toxin
medical therapies
raynaud's phenomenon
  • 0 views
  • 22 Mar, 2022
  • 1 location
Phase II/III Double-blind Randomized Placebo-controlled Trial Assessing the Preventive Effect of Clopidogrel on the Systemic Sclerosis Development Risk in Subjects With Specific Dysimmunity and Raynaud Phenomenon (PSSIT)

specific autoantibodies. The association of Raynaud phenomenon and SSc-specific anti-nuclear antibodies is the hallmark of pre-scleroderma subjects, among who around 47% declare a complete disease after

raynaud's syndrome
scleroderma
raynaud's phenomenon
vascular disease
fibrosis
  • 0 views
  • 28 Oct, 2022
  • 1 location
Rheopheresis for Raynaud's and Digital Ulcers in Systemic Sclerosis (RHEACT)

In this feasibility study, we aim to explore therapeutic Rheopheresis (RheoP) as a novel treatment option for SSc-associated Raynaud's phenomenon and/or digital ulcers and compare it to the

raynaud's syndrome
raynaud's phenomenon
systemic sclerosis
ulceration
  • 0 views
  • 07 Apr, 2022
  • 1 location
Exercise in People With Systemic Sclerosis (SScPF)

Raynaud's phenomenon and digital ulceration are two of the most common disease manifestations leading to digital and/or toe pain in systemic sclerosis (SSc). In addition to pain, fatigue has

raynaud's syndrome
raynaud's phenomenon
  • 0 views
  • 04 Oct, 2022
  • 1 location
Effectiveness of the EmoLED Medical Device in the Healing of Digital Ulcers in Patients With Scleroderma. (SUITABLE)

The present clinical study aims to compare, in the two groups of patients with acral ulcers, the reparative process of the injured area, the evaluation of the healing time (with "healing" interpreted as the complete re-epithelization of the wound) and the perception of pain through NRS scale.

scleroderma
  • 0 views
  • 11 May, 2022
  • 1 location
Cohort of Patients With Systemic Sclerosis Within the Framework of the RESO Reference Centre

Systemic sclerosis (SSc) is a rare form of connective tissue disease characterized by vascular involvement and the intensity of fibrosis. The lack of available treatment is largely due to the very fragmented understanding of the pathophysiology of SSc. However, one of the keys to conducting quality research on this disease …

rheumatism
raynaud's syndrome
scleroderma
raynaud's phenomenon
fibrosis
  • 0 views
  • 16 May, 2021
  • 1 location
Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation

In this pilot and feasibility study, the investigators will enroll patients with frequent symptomatic episodes of atrial fibrillation (AF) in a cross-over study testing two different classes of anti arrhythmic drugs (AADs). This pilot and feasibility study will provide preliminary data for a larger study in which the investigators will …

sotalol
antiarrhythmic drug
fibrillation
flecainide
  • 319 views
  • 08 Jul, 2022
  • 1 location
Application for Monitoring and Evaluation of Raynaud's Phenomenon (RaynaudMoni)

To evaluate the feasibility of using a smartphone application for monitoring and evaluation of Raynaud's Phenomenon.

raynaud's phenomenon
  • 32 views
  • 26 May, 2022
  • 1 location
Follow-up of SPTS in Patients With Raynaud's Phenomenon

Background: Raynaud's phenomenon is a vasospasm of the extremities, leading to extensive discomfort in daily life and potentially severe ischemia. Some patients are resistant to conventional

discomfort
ischemia
raynaud's phenomenon
vasospasm
  • 213 views
  • 12 Feb, 2022
  • 1 location